Stellar Bancorp, Inc.
Material Litigation
confidence 85%
filed 2026-05-20
Item 8.01
The filing discloses three lawsuits challenging the proposed merger between Stellar Bancorp and Prosperity Bancshares, filed in New York Supreme Court in May 2026, plus demand letters from purported shareholders. Although the companies deny merit and made supplemental disclosures to avoid litigation delays, the disclosure of material litigation related to a pending merger transaction is a core 8-K Item 8.01 event that would affect a reasonable investor's assessment of transaction risk and timing.
View raw filing on EDGAR →
Cardiff Oncology, Inc.
Material Litigation
confidence 95%
filed 2026-05-19
Item 8.01
Cardiff Oncology filed a lawsuit against Nerviano Medical Sciences in U.S. District Court for the Southern District of California seeking injunctive relief and declaratory judgment regarding an alleged material breach of a license agreement for onvansertib. The dispute centers on patent inventorship obligations and continuation patent applications, with Cardiff disputing NMS's breach allegations. This is a material litigation event that would affect investor assessment of the company's ability to maintain its license rights and product development.
View raw filing on EDGAR →